{"issuance_frequency":"","notes_translated":{"fr":"En mai 2021, des rapports internationaux de myocardite (inflammation du muscle cardiaque) et de péricardite (inflammation de la paroi autour du cœur) après l'administration du vaccin à ARNm contre la COVID-19 sont apparus, notamment en Israël (en anglais seulement) et aux États-Unis (en anglais seulement). Le suivi de ces cas est en cours. Aucune association nette n'a été établie entre la myocardite ou la péricardite et les vaccins à ARNm, et à ce jour, aucune mesure réglementaire n'a été prise au Canada ou à l'étranger.","en":"In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Follow-up on these cases is ongoing. No clear association has been established between myocarditis/pericarditis and mRNA vaccines, and to date, no regulatory action has been taken in Canada or internationally."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"01bb81fa-699f-4aa1-aa76-fdb2eea1721e","metadata_created":"2021-07-27T20:11:58.280469","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-08-31T20:40:51.126415","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["En mai 2021","des rapports internationaux","inflammation du muscle cardiaque","inflammation de la paroi","autour du cœur","après l'administration","du vaccin à ARNm","contre la COVID-19","apparus","notamment en Israël","aux États-Unis","Aucune association","aucune mesure réglementaire","prise au Canada","ou à l'étranger","Situation au Canada","Rapports de myocardite","péricardite","après l’administration","vaccin contre la COVID-19","Communiqué","aux professionnels de la santé","myocardite","péricardite","Vaccin contre le COVID-19","vaccination","COVID-19","professionnels de la santé","ARNm","Dans le cadre des efforts","continus déployés","pour assurer l'innocuité du vaccin","contre la COVID-19","l'Agence de la santé publique du Canada","ASPC","SC","Santé Canada","surveille de près","la myocardite et la péricardite","dans les systèmes canadien","de surveillance passive et active","de l'innocuité","dont le Système canadien","de surveillance des effets secondaires","suivant l'immunisation","SCSESSI","le Programme Canada Vigilance","CV","le Canadian National","Vaccine Safety Network","CANVAS","le Programme canadien de surveillance","active de l'immunisation","(IMPACT)","SRAS-CoV-2","coronavirus","COVID","IMPACT"],"en":["Situation au Canada","Reports of myocarditis","pericarditis","after COVID-19 vaccination","Communiqué","to health practitioners","myocarditis","pericarditis","COVID-19 vaccination","vaccination","COVID-19","health practitioners","mRNA","COVID-19 vaccine","safety efforts","PHAC","Public Health Agency of Canada","Health Canada","HC","monitoring myocarditis","pericarditis","in passive and active","Canadian safety","surveillance systems","Canadian Adverse Events","Immunization Surveillance System","CAEFISS","Canada Vigilance Program","CV","Canadian National","Vaccine Safety Network","CANVAS","Canadian Immunization","Monitoring Program ACTive","(IMPACT)","SRAS-CoV-2","coronavirus","COVID","IMPACT","inflammation of the heart muscle","inflammation","lining around the heart","following vaccination","with COVID-19","mRNA vaccines emerged","including from Israel","no regulatory action","in Canada","internationally","may 2021"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Rapports de myocardite ou péricardite après l’administration du vaccin contre la COVID-19 : Communiqué aux professionnels de la santé ","en":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners "},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"01bb81fa-699f-4aa1-aa76-fdb2eea1721e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"79145403-098b-4697-87e6-1d45235feb59","state":"active","name_translated":{"fr":"Rapports de myocardite ou péricardite après l’administration du vaccin contre la COVID-19 : Communiqué aux professionnels de la santé ","en":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners ","language":["en"],"created":"2021-07-27T20:11:58.384910","url":"https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/reports-myocarditis-pericarditis-after-vaccination-communique-health-practitioners-june-3-2021.html","last_modified":null,"position":0,"revision_id":"e15ac2ca-2fff-41df-9d15-0302885b25f2","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"01bb81fa-699f-4aa1-aa76-fdb2eea1721e","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"58c5f75b-f95b-4527-b21e-c4c86e4cdb90","state":"active","name_translated":{"fr":"Rapports de myocardite ou péricardite après l’administration du vaccin contre la COVID-19 : Communiqué aux professionnels de la santé ","en":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners ","language":["fr"],"created":"2021-07-27T20:11:58.384915","url":"https://www.canada.ca/fr/sante-publique/services/maladies/2019-nouveau-coronavirus/document-orientation/rapports-myocardite-pericardite-apres-administration-vaccin-communique-professionnels-sante-3-juin-2021.html","last_modified":null,"position":1,"revision_id":"e15ac2ca-2fff-41df-9d15-0302885b25f2","resource_type":"website"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-06-14 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"01bb81fa-699f-4aa1-aa76-fdb2eea1721e","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Follow-up on these cases is ongoing. No clear association has been established between myocarditis/pericarditis and mRNA vaccines, and to date, no regulatory action has been taken in Canada or internationally.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners ","revision_id":"13781b85-ff0c-439b-8fe9-b841a0601091"}